New Details About FDA's CBD Regulation Plans

Food and Drug Administration (FDA) Commissioner Scott Gottlieb took a break from combing his hair back, and revealed new details about plans to pursue alternative pathways for CBD regulation. He also acknowledged that federal prohibition drives research into medical marijuana overseas on Wednesday.

Get all of the details on the Commissioner's hearing before a House Appropriations subcommittee from Kyle Jaeger's new article on

Weed on Cape Cod: A Ptownie Production